Labcorp Holdings Change in Accounts Receivable 2010-2025 | LH

Labcorp Holdings annual/quarterly change in accounts receivable history and growth rate from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
  • Labcorp Holdings change in accounts receivable for the quarter ending March 31, 2025 was $-0.167B, a 35.47% increase year-over-year.
  • Labcorp Holdings change in accounts receivable for the twelve months ending March 31, 2025 was $-0.475B, a 57.05% increase year-over-year.
  • Labcorp Holdings annual change in accounts receivable for 2024 was $-0.022B, a 70.92% decline from 2023.
  • Labcorp Holdings annual change in accounts receivable for 2023 was $-0.075B, a 425.97% decline from 2022.
  • Labcorp Holdings annual change in accounts receivable for 2022 was $0.023B, a 89.79% decline from 2021.
Labcorp Holdings Annual Change in Accounts Receivable
(Millions of US $)
2024 $-22
2023 $-75
2022 $23
2021 $226
2020 $-956
2019 $-123
2018 $-31
2017 $-9
2016 $-90
2015 $-89
2014 $-31
2013 $-68
2012 $1
2011 $-37
2010 $-25
2009 $74
Sector Industry Market Cap Revenue
Medical Medical Services $22.089B $13.009B
Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.067B 27.09
CVS Health (CVS) United States $78.811B 9.80
Elevance Health (ELV) United States $66.101B 8.89
Cencora (COR) United States $56.558B 19.68
DiDi Global (DIDIY) China $24.238B 25.75
Natera (NTRA) United States $19.248B 0.00
BioMerieux (BMXMF) France $17.068B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.897B 0.00
ICON (ICLR) Ireland $14.657B 14.10
CochLear (CHEOY) Australia $13.278B 0.00
Solventum (SOLV) United States $12.626B 13.37
Medpace Holdings (MEDP) United States $12.299B 32.55
Revvity (RVTY) United States $10.708B 18.58
Viatris (VTRS) United States $10.563B 3.63
Avantor (AVTR) United States $9.404B 13.66
Sonic Healthcare (SKHHY) Australia $8.886B 0.00
Charles River Laboratories (CRL) United States $8.654B 16.96
HealthEquity (HQY) United States $8.544B 37.42
Caris Life Sciences,�Inc (CAI) United States $7.505B 0.00
Bausch + Lomb (BLCO) Canada $4.851B 32.64
Amplifon S.p.A (AMFPF) Italy $3.871B 21.19
BrightSpring Health Services (BTSG) United States $3.746B 34.37
Sotera Health (SHC) United States $3.382B 19.22
GeneDx Holdings (WGS) United States $2.953B 68.10
Surgery Partners (SGRY) United States $2.867B 37.28
Concentras Parent (CON) United States $2.615B 15.11
Organon (OGN) United States $2.610B 2.77
Alignment Healthcare (ALHC) United States $2.572B 0.00
Progyny (PGNY) United States $2.014B 44.34
Premier (PINC) United States $1.772B 13.45
GoodRx Holdings (GDRX) United States $1.747B 34.93
PACS (PACS) United States $1.710B 0.00
Ardent Health (ARDT) United States $1.528B 6.51
Teladoc Health (TDOC) United States $1.298B 0.00
Establishment Labs Holdings (ESTA) $1.213B 0.00
Pediatrix Medical (MD) United States $1.065B 8.10
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
QDM (QDMI) Hong Kong, SAR China $0.875B 300.00
Agilon Health (AGL) United States $0.791B 0.00
CareDx (CDNA) United States $0.716B 11.18
AMN Healthcare Services Inc (AMN) United States $0.712B 6.67
Embecta (EMBC) United States $0.611B 4.11
So-Young (SY) China $0.501B 0.00
InnovAge Holding (INNV) United States $0.479B 0.00
Sonida Senior Living (SNDA) United States $0.471B 0.00
Nutex Health (NUTX) United States $0.467B 7.06
LifeMD (LFMD) United States $0.459B 0.00
Omada Health (OMDA) $0.455B 0.00
SBC Medicals (SBC) United States $0.455B 0.00
Auna S.A (AUNA) Luxembourg $0.454B 10.23
COMPASS Pathways (CMPS) United Kingdom $0.369B 0.00
Enhabit (EHAB) United States $0.338B 27.83
Oncology Institute (TOI) United States $0.329B 0.00
Performant Healthcare (PHLT) United States $0.270B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.145B 23.67
Sera Prognostics (SERA) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.096B 0.00
IceCure Medical (ICCM) Israel $0.061B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
KindlyMD (NAKA) United States $0.058B 0.00
Biodesix (BDSX) United States $0.055B 0.00
ModivCare (MODV) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.041B 0.00
Basel Medical Group (BMGL) Singapore $0.039B 0.00
OSR Holdings (OSRH) United States $0.017B 0.00
BioNexus Gene Lab (BGLC) $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
Pheton Holdings (PTHL) China $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00